[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":613,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.26,"TPM_sd":13.52,"TPM_min":0,"TPM_25th_percentile":1.87,"TPM_median":3.78,"TPM_75th_percentile":8.15,"TPM_max":118.93},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":210,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.57,"TPM_sd":0.92,"TPM_min":0,"TPM_25th_percentile":0.14,"TPM_median":0.28,"TPM_75th_percentile":0.53,"TPM_max":7},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 53)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":53,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.41,"TPM_sd":4.23,"TPM_min":0.13,"TPM_25th_percentile":1.11,"TPM_median":1.62,"TPM_75th_percentile":2.29,"TPM_max":30.55},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":59,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":15.06,"TPM_sd":76.41,"TPM_min":0.12,"TPM_25th_percentile":1.29,"TPM_median":2.49,"TPM_75th_percentile":7.59,"TPM_max":590.45},{"x_label":"Central neurocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Central neurocytoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000856","MONDO":"MONDO_0019134","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.78,"TPM_sd":5.17,"TPM_min":1.53,"TPM_25th_percentile":1.81,"TPM_median":2.08,"TPM_75th_percentile":6.41,"TPM_max":10.74},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.05,"TPM_sd":5.48,"TPM_min":0,"TPM_25th_percentile":0.14,"TPM_median":0.44,"TPM_75th_percentile":0.82,"TPM_max":14.29},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.08,"TPM_sd":11.23,"TPM_min":0.59,"TPM_25th_percentile":2.58,"TPM_median":4.02,"TPM_75th_percentile":10.6,"TPM_max":38.38},{"x_label":"Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 26)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus papilloma","GTEx_tissue_subgroup":"","EFO":"EFO_1000177","MONDO":"MONDO_0009837","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.32,"TPM_sd":0.27,"TPM_min":0,"TPM_25th_percentile":0.12,"TPM_median":0.29,"TPM_75th_percentile":0.47,"TPM_max":1.24},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 18)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":18,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":31.05,"TPM_sd":36.5,"TPM_min":0.96,"TPM_25th_percentile":2.38,"TPM_median":14.6,"TPM_75th_percentile":55.36,"TPM_max":119.86},{"x_label":"CNS neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0006130","GTEx_tissue_subgroup_UBERON":"","TPM_mean":21.89,"TPM_sd":13.55,"TPM_min":13.76,"TPM_25th_percentile":14.07,"TPM_median":14.38,"TPM_75th_percentile":25.96,"TPM_max":37.53},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 22)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":22,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.08,"TPM_sd":2.56,"TPM_min":0.18,"TPM_25th_percentile":0.29,"TPM_median":0.49,"TPM_75th_percentile":0.75,"TPM_max":12.47},{"x_label":"Desmoplastic infantile astrocytoma and ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Desmoplastic infantile astrocytoma and ganglioglioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0022963","MONDO":"MONDO_0022963","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.84,"TPM_sd":1.24,"TPM_min":0.62,"TPM_25th_percentile":1.21,"TPM_median":1.79,"TPM_75th_percentile":2.45,"TPM_max":3.1},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.27,"TPM_sd":8.64,"TPM_min":0.63,"TPM_25th_percentile":1.87,"TPM_median":4.48,"TPM_75th_percentile":11.81,"TPM_max":26.77},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":164,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.11,"TPM_sd":8.4,"TPM_min":0.32,"TPM_25th_percentile":2.88,"TPM_median":5.79,"TPM_75th_percentile":10.16,"TPM_max":61.66},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":39,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.59,"TPM_sd":4.05,"TPM_min":0.51,"TPM_25th_percentile":2.57,"TPM_median":5.13,"TPM_75th_percentile":7.93,"TPM_max":17.78},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":36.64,"TPM_sd":28.87,"TPM_min":0.35,"TPM_25th_percentile":13.8,"TPM_median":31.35,"TPM_75th_percentile":60.9,"TPM_max":78.85},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":163,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.94,"TPM_sd":2.21,"TPM_min":0.03,"TPM_25th_percentile":0.6,"TPM_median":1.03,"TPM_75th_percentile":2.51,"TPM_max":12.31},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.91,"TPM_sd":7.59,"TPM_min":0.77,"TPM_25th_percentile":2.28,"TPM_median":7.72,"TPM_75th_percentile":14.87,"TPM_max":24.07},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":80,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.1,"TPM_sd":1.98,"TPM_min":0.16,"TPM_25th_percentile":0.83,"TPM_median":1.29,"TPM_75th_percentile":2.82,"TPM_max":8.99},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 46)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":46,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":42.75,"TPM_sd":58.21,"TPM_min":0.47,"TPM_25th_percentile":2.19,"TPM_median":9.25,"TPM_75th_percentile":69.06,"TPM_max":218.01},{"x_label":"Ganglioneuroma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioneuroma","GTEx_tissue_subgroup":"","EFO":"EFO_0000500","MONDO":"MONDO_0005033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.63,"TPM_sd":0.25,"TPM_min":0.34,"TPM_25th_percentile":0.53,"TPM_median":0.72,"TPM_75th_percentile":0.77,"TPM_max":0.82},{"x_label":"Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Germinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.6,"TPM_sd":11.24,"TPM_min":0.75,"TPM_25th_percentile":2.97,"TPM_median":7.5,"TPM_75th_percentile":13.66,"TPM_max":38.86},{"x_label":"Glial-neuronal tumor NOS  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor NOS","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.99,"TPM_sd":9.59,"TPM_min":0.32,"TPM_25th_percentile":1.37,"TPM_median":3.87,"TPM_75th_percentile":11.33,"TPM_max":40.13},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.79,"TPM_sd":0.39,"TPM_min":0.33,"TPM_25th_percentile":0.59,"TPM_median":0.66,"TPM_75th_percentile":1.11,"TPM_max":1.27},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.03,"TPM_sd":11.12,"TPM_min":0.33,"TPM_25th_percentile":2.59,"TPM_median":5.18,"TPM_75th_percentile":11.66,"TPM_max":85.23},{"x_label":"High-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.11,"TPM_sd":21.88,"TPM_min":0.16,"TPM_25th_percentile":1.41,"TPM_median":3.96,"TPM_75th_percentile":7.29,"TPM_max":133.7},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.62,"TPM_sd":8.78,"TPM_min":0.66,"TPM_25th_percentile":1.92,"TPM_median":5.84,"TPM_75th_percentile":9.98,"TPM_max":25.47},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 400)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":400,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.03,"TPM_sd":3.04,"TPM_min":0.05,"TPM_25th_percentile":1.91,"TPM_median":3.37,"TPM_75th_percentile":5.44,"TPM_max":23.12},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.92,"TPM_sd":7.06,"TPM_min":0.27,"TPM_25th_percentile":1.37,"TPM_median":3.98,"TPM_75th_percentile":8.52,"TPM_max":34.48},{"x_label":"Malignant peripheral nerve sheath tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Malignant peripheral nerve sheath tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0000760","MONDO":"MONDO_0017827","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.76,"TPM_sd":1.29,"TPM_min":0.31,"TPM_25th_percentile":0.73,"TPM_median":1.66,"TPM_75th_percentile":2.67,"TPM_max":3.49},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":237,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":40.68,"TPM_sd":33.63,"TPM_min":1.35,"TPM_25th_percentile":18.51,"TPM_median":31.18,"TPM_75th_percentile":48.98,"TPM_max":212.34},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.71,"TPM_sd":0.55,"TPM_min":0,"TPM_25th_percentile":0.32,"TPM_median":0.58,"TPM_75th_percentile":0.87,"TPM_max":2.56},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 317)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":317,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":50.44,"TPM_sd":42.61,"TPM_min":0.3,"TPM_25th_percentile":24.08,"TPM_median":37.61,"TPM_75th_percentile":62.15,"TPM_max":323.67},{"x_label":"Neuroblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.36,"TPM_sd":12.25,"TPM_min":0.3,"TPM_25th_percentile":2.4,"TPM_median":12.84,"TPM_75th_percentile":24.51,"TPM_max":26.85},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":137,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":79.97,"TPM_sd":49.74,"TPM_min":1.74,"TPM_25th_percentile":44.53,"TPM_median":67.96,"TPM_75th_percentile":109.02,"TPM_max":323.67},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.45,"TPM_sd":0.25,"TPM_min":0,"TPM_25th_percentile":0.27,"TPM_median":0.5,"TPM_75th_percentile":0.66,"TPM_max":0.83},{"x_label":"Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Non-germinomatous germ cell tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.67,"TPM_sd":6.48,"TPM_min":0.25,"TPM_25th_percentile":0.35,"TPM_median":0.52,"TPM_75th_percentile":2.03,"TPM_max":15.18},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 30)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":30,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.13,"TPM_sd":1.73,"TPM_min":0.01,"TPM_25th_percentile":0.82,"TPM_median":1.81,"TPM_75th_percentile":2.81,"TPM_max":7.03},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.36,"TPM_sd":13.68,"TPM_min":1.76,"TPM_25th_percentile":4.89,"TPM_median":12.48,"TPM_75th_percentile":31.82,"TPM_max":35.57},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.08,"TPM_sd":3.19,"TPM_min":0,"TPM_25th_percentile":0.16,"TPM_median":0.68,"TPM_75th_percentile":1.78,"TPM_max":10.72},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":27,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.85,"TPM_sd":0.47,"TPM_min":0.23,"TPM_25th_percentile":0.54,"TPM_median":0.71,"TPM_75th_percentile":1.08,"TPM_max":2.08},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.44,"TPM_sd":10.86,"TPM_min":0.07,"TPM_25th_percentile":0.35,"TPM_median":0.94,"TPM_75th_percentile":3.91,"TPM_max":33.47},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary and Relapse Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.65,"TPM_sd":3.65,"TPM_min":0.2,"TPM_25th_percentile":3.79,"TPM_median":6.19,"TPM_75th_percentile":9.2,"TPM_max":18.48},{"x_label":"Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 289)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":289,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Colon Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1001949","MONDO":"MONDO_0002271","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.78,"TPM_sd":1.39,"TPM_min":0.06,"TPM_25th_percentile":0.79,"TPM_median":1.47,"TPM_75th_percentile":2.27,"TPM_max":9.22},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":165,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.38,"TPM_sd":25.6,"TPM_min":0.75,"TPM_25th_percentile":5.3,"TPM_median":11.04,"TPM_75th_percentile":25.51,"TPM_max":171.81},{"x_label":"Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 371)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":371,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Hepatocellular Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000182","MONDO":"MONDO_0007256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.35,"TPM_sd":0.77,"TPM_min":0,"TPM_25th_percentile":0.08,"TPM_median":0.15,"TPM_75th_percentile":0.32,"TPM_max":9.18},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":521,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":19.26,"TPM_sd":15.69,"TPM_min":0.97,"TPM_25th_percentile":9.27,"TPM_median":15.46,"TPM_75th_percentile":24.97,"TPM_max":123.38},{"x_label":"Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 512)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":512,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000571","MONDO":"MONDO_0005061","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.78,"TPM_sd":8.1,"TPM_min":0.06,"TPM_25th_percentile":0.47,"TPM_median":0.96,"TPM_75th_percentile":2.37,"TPM_max":129.19},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":378,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.06,"TPM_sd":4.58,"TPM_min":0.08,"TPM_25th_percentile":0.8,"TPM_median":1.59,"TPM_75th_percentile":3.31,"TPM_max":44.87},{"x_label":"Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 93)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":93,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Rectum Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005631","MONDO":"MONDO_0002169","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.72,"TPM_sd":1.36,"TPM_min":0.26,"TPM_25th_percentile":0.87,"TPM_median":1.22,"TPM_75th_percentile":2.13,"TPM_max":6.32},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":261,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.82,"TPM_sd":6.25,"TPM_min":0.15,"TPM_25th_percentile":1.3,"TPM_median":2.63,"TPM_75th_percentile":5.94,"TPM_max":51.12},{"x_label":"Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 179)","specimen_descriptor_fill":"TCGA Primary and Relapse Tumors","box_sample_count":179,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Corpus Endometrial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0007532","MONDO":"MONDO_0000553","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.73,"TPM_sd":8.95,"TPM_min":0.1,"TPM_25th_percentile":1.43,"TPM_median":3.75,"TPM_75th_percentile":8.45,"TPM_max":69.48}]